Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Akero Therapeutics Inc buy Citigroup Inc.

Akero Therapeutics Inc
Start price
€27.54
18.11.24 / 50%
Target price
€61.49
18.11.25
Performance (%)
69.39%
End price
€46.65
19.11.25
Summary
This prediction ended on 19.11.25 with a price of €46.65. The BUY prediction by Citigroup_Inc_ for Akero Therapeutics Inc saw massive gains of 69.39%. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Akero Therapeutics Inc - - -
iShares Core DAX® -2.796% -1.396% -0.221%
iShares Nasdaq 100 -6.352% -0.407% 28.998%
iShares Nikkei 225® -6.943% -0.275% 48.214%
iShares S&P 500 -3.410% 0.396% 20.281%

Comments by Citigroup_Inc_ for this prediction

In the thread Akero Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 69.39%
Target price 61.490
Change
Ends at 18.11.25

Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $65.00 price target on the stock.
Ratings data for AKRO provided by MarketBeat

Citigroup Inc. 
0
Report Share
18.11.24
In the thread Trading Akero Therapeutics Inc
Prediction Buy
Perf. (%) 69.39%
Target price 61.490
Change
Ends at 18.11.25

Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

Citigroup Inc. 
0
Report Share
19.11.25

Stopped prediction by Citigroup_Inc_ for Akero Therapeutics Inc

buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€35.77
13.05.25
€70.22
13.05.26
31.31%
14.05.26

Citigroup Inc. 
13.05.25 50%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€53.14
28.01.25
€76.71
28.01.26
-11.61%
29.01.26

Citigroup Inc. 
28.01.25 50%